U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H26ClN5OS
Molecular Weight 419.971
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Tildacerfont

SMILES

CCC(CC)C1=CC(C)=NC2=C(C(C)=NN12)C3=C(Cl)SC(=N3)N4CCOCC4

InChI

InChIKey=CLKXPWDYEYIPFS-UHFFFAOYSA-N
InChI=1S/C20H26ClN5OS/c1-5-14(6-2)15-11-12(3)22-19-16(13(4)24-26(15)19)17-18(21)28-20(23-17)25-7-9-27-10-8-25/h11,14H,5-10H2,1-4H3

HIDE SMILES / InChI
Molecular Formula C20H26ClN5OS
Molecular Weight 419.971
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
139594
Substance Class Chemical
Created
by admin
on Sat Dec 16 13:20:06 GMT 2023
Edited
by admin
on Sat Dec 16 13:20:06 GMT 2023
Record UNII
09QCEV5481
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Tildacerfont
INN  
Official Name English
PYRAZOLO(1,5-A)PYRIMIDINE, 3-(4-CHLORO-2-(4-MORPHOLINYL)-5-THIAZOLYL)-7-(1-ETHYLPROPYL)-2,5-DIMETHYL-
Systematic Name English
tildacerfont [INN]
Common Name English
TILDACERFONT [USAN]
Common Name English
3-(5-CHLORO-2-MORPHOLIN-4-YL-THIAZOL-4-YL)-7-(1-ETHYL-PROPYL)-2,5-DIMETHYL-PYRAZOLO(1,5-A)PYRIMIDINE
Systematic Name English
PYRAZOLO(1,5-A)PYRIMIDINE, 3-(4-CHLORO-2-(4-MORPHOLINYL)-5-THIAZOLYL)-7-(1-ETHYLPROPYL)-2,5-DIMETHYL-PYRAZOLO(1,3-A)PYRIMIDINE
Systematic Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/17/1968
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
FDA ORPHAN DRUG 612217
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
Code System Code Type Description
FDA UNII
09QCEV5481
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
PRIMARY
CAS
1014983-00-6
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
PRIMARY
PUBCHEM
134694266
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
PRIMARY
USAN
LM-194
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
PRIMARY
INN
10884
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
PRIMARY
NCI_THESAURUS
C171816
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
PRIMARY
SMS_ID
100000177412
Created by admin on Sat Dec 16 13:20:07 GMT 2023 , Edited by admin on Sat Dec 16 13:20:07 GMT 2023
PRIMARY
Related Record Type Details
MULTIDRUG RESISTANCE PROTEIN 1
TRANSPORTER -> NON-SUBSTRATE
CYTOCHROME P450 3A4
METABOLIC ENZYME -> SUBSTRATE
ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2
TRANSPORTER -> NON-SUBSTRATE
MULTIDRUG RESISTANCE PROTEIN 1
TRANSPORTER -> INHIBITOR
IC50
CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1
TARGET -> INHIBITOR
COMPETITIVE INHIBITOR
Ki
ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2
TRANSPORTER -> INHIBITOR
IC50
Related Record Type Details
Structure of Tildacerfont
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966